122 related articles for article (PubMed ID: 36529450)
1. Validation of a specialized evaluation system for COVID-19 in Japan: A retrospective, multicenter cohort study.
Furuhata H; Araki K
J Infect Chemother; 2023 Mar; 29(3):294-301. PubMed ID: 36529450
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of COVID-19: Clinical Dynamics of Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection Detected by Early Active Surveillance.
Suh HJ; Kim DH; Heo EY; Lee HW; Lee JK; Lee CS; Kim M; Jeon YD; Chung JW; Kim YK; Shin PJ; Lee MS; Kang JS; Lee MJ; Kim BN; Park SW
J Korean Med Sci; 2020 Aug; 35(32):e297. PubMed ID: 32808513
[TBL] [Abstract][Full Text] [Related]
3. The Association of Work-related Stress According to the Demand-Control Model With Aggravation of Pre-existing Disease During the First State of COVID-19 Emergency in Japan.
He Y; Yatsuya H; Chiang C; Ota A; Okubo R; Ishimaru T; Tabuchi T
J Epidemiol; 2021 Dec; 31(12):642-647. PubMed ID: 34544998
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19).
Wang X; Hu X; Tan W; Mazzone P; Mireles-Cabodevila E; Han X; Huang P; Hu W; Dweik R; Cheng Z
AJR Am J Roentgenol; 2021 Jul; 217(1):83-92. PubMed ID: 32903056
[No Abstract] [Full Text] [Related]
5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021.
Choi YY; Choi SH; Choi JH; Kim DH; Lee JK; Eun BW; Lee H; Kim YK; Ahn B; Song SH; Yun KW
J Korean Med Sci; 2022 Oct; 37(42):e303. PubMed ID: 36325607
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study.
Matsuzawa Y; Ogawa H; Kimura K; Konishi M; Kirigaya J; Fukui K; Tsukahara K; Shimizu H; Iwabuchi K; Yamada Y; Saka K; Takeuchi I; Hirano T; Tamura K
Hypertens Res; 2020 Nov; 43(11):1257-1266. PubMed ID: 32820236
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
11. Aspiration of periodontopathic bacteria due to poor oral hygiene potentially contributes to the aggravation of COVID-19.
Takahashi Y; Watanabe N; Kamio N; Kobayashi R; Iinuma T; Imai K
J Oral Sci; 2020 Dec; 63(1):1-3. PubMed ID: 33177276
[TBL] [Abstract][Full Text] [Related]
12. The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study.
Nishimoto Y; Yachi S; Takeyama M; Tsujino I; Nakamura J; Yamamoto N; Nakata H; Ikeda S; Umetsu M; Aikawa S; Hayashi H; Satokawa H; Okuno Y; Iwata E; Ogihara Y; Ikeda N; Kondo A; Iwai T; Yamada N; Ogawa T; Kobayashi T; Mo M; Yamashita Y;
J Cardiol; 2022 Oct; 80(4):285-291. PubMed ID: 35430141
[TBL] [Abstract][Full Text] [Related]
13. Clinical profiles and outcome of patients with COVID-19 in a specialized hospital in Japan.
Oda Y; Shiraishi S; Shimada M; Kurai O
J Anesth; 2021 Jun; 35(3):405-411. PubMed ID: 33661358
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
Wang QQ; Kaelber DC; Xu R; Volkow ND
Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
[TBL] [Abstract][Full Text] [Related]
15. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study.
Kitajima H; Hirashima T; Suzuki H; Arai T; Tamura Y; Hashimoto S; Morishita H; Matsuoka H; Kashiwa Y; Han Y; Minamoto S; Tanaka T; Nagai T
J Infect Chemother; 2021 Aug; 27(8):1217-1222. PubMed ID: 34023221
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
[TBL] [Abstract][Full Text] [Related]
20. High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.
Schaffrath J; Brummer C; Wolff D; Holtick U; Kröger N; Bornhäuser M; Kraus S; Hilgendorf I; Blau IW; Penack O; Wittke C; Steiner N; Nachbaur D; Thurner L; Hindahl H; Zeiser R; Maier CP; Bethge W; Müller LP
Transplant Cell Ther; 2022 Jun; 28(6):337.e1-337.e10. PubMed ID: 35296445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
